MedPath

Feasibility of Breast Cancer Risk Evaluation in Women From the General Population

Conditions
Breastcancer
Registration Number
NCT02997384
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Brief Summary

This study aims to evaluate the feasibility (acceptability) of a consultation dedicated to informing women about their risk of breast cancer and the screening methods recommended for them according to the recommendations in force during a routine consultation at a general practitioner, a gynecologist or a radiologist.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • Woman from 40 to 74 years old
  • Understanding the French language
Exclusion Criteria

Women will not be eligible for study if they are in any of the following situations:

  • Cancer active or in the course of treatment type surgery, chemotherapy, or radiotherapy, whether breast or other organ
  • Recent diagnosis <1 year of suspicious or cancerous lesions
  • Psychiatric pathology not compatible with the study
  • Poor understanding of the French language

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of women who agreed to measure their risk with personalized surveillance and screening recommendations during the consultationup to 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gustave Roussy

🇫🇷

Villejuif, Val de Marne, France

Gustave Roussy
🇫🇷Villejuif, Val de Marne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.